Spyre Therapeutics presents IBD antibody data at UEGW 2026

October 18, 2026 9:30 AM

Spyre Therapeutics, Inc. (NASDAQ: SYRE) presented clinical and preclinical data at United European Gastroenterology Week (UEGW) 2026 in Barcelona, according ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found